Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study
Titel:
Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study
Auteur:
van Ommen-Nijhof, A. Steenbruggen, T.G. Wiersma, T.G. Balduzzi, S. Daletzakis, A. Holtkamp, M.J. Delfos, M. Schot, M. Beelen, K. Siemerink, E.J.M. Heijns, J. Mandjes, I.A. Wesseling, J. Rosenberg, E.H. Vrancken Peeters, M.J.T. Linn, S.C. Sonke, G.S.